Literature DB >> 18585466

Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.

Yoko Ikoma1, Hiroshi Ito, Ryosuke Arakawa, Masaki Okumura, Chie Seki, Miho Shidahara, Hidehiko Takahashi, Yuichi Kimura, Iwao Kanno, Tetsuya Suhara.   

Abstract

Dopamine D(2) receptor occupancy by antipsychotic drugs has been measured with positron emission tomography (PET) by comparing the binding potential (BP) values before and after drug administration. This occupancy has been found to be related to clinical effects and side effects. In this study, we evaluated the uncertainty of the quantitative analysis for estimating the dopamine D(2) receptor occupancy by antipsychotics in simulation and human studies of [(11)C]raclopride and for the high affinity ligand [(11)C]FLB 457. Time-activity curves of [(11)C]raclopride and [(11)C]FLB 457 were simulated, and the reliability of BP estimated by a simplified reference tissue model and the calculated occupancy were investigated for various noise levels, BP values, and scan durations. Then, in the human PET study with and without antipsychotics, the uncertainty of BP and occupancy estimates and the scan duration required for a reliable estimation were investigated by a bootstrap approach. Reliable and unbiased estimates of [(11)C]raclopride BP(ND) could be obtained with recording as short as 32 min, with the relative standard deviation (SD) of the striatal occupancy remaining less than 10%. Conversely, in [(11)C]FLB 457 studies, the mean value increased and SD of the temporal cortex and thalamus exceeded 10% when the scan duration was shorter than 60 min. These results demonstrated that dopamine D(2) receptor occupancy by antipsychotics can be estimated precisely with an optimal scan duration with [(11)C]raclopride and [(11)C]FLB 457.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585466     DOI: 10.1016/j.neuroimage.2008.05.056

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  6 in total

1.  Measurement error analysis for the determination of dopamine D(2) receptor occupancy using the agonist radioligand [(11)C]MNPA.

Authors:  Miho Shidahara; Hiroshi Ito; Tatsui Otsuka; Yoko Ikoma; Ryosuke Arakawa; Fumitoshi Kodaka; Chie Seki; Harumasa Takano; Hidehiko Takahashi; Federico E Turkheimer; Yuichi Kimura; Iwao Kanno; Tetsuya Suhara
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

2.  The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.

Authors:  Ingo Vernaleken; Lisa Peters; Mardjan Raptis; Robert Lin; Hans-Georg Buchholz; Yun Zhou; Oliver Winz; Frank Rösch; Peter Bartenstein; Dean F Wong; Wolfgang M Schäfer; Gerhard Gründer
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-18       Impact factor: 6.200

Review 3.  Advances in simultaneous PET/MR for imaging neuroreceptor function.

Authors:  Christin Y Sander; Hanne D Hansen; Hsiao-Ying Wey
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-13       Impact factor: 6.200

4.  Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation.

Authors:  Christin Y Sander; Joseph B Mandeville; Hsiao-Ying Wey; Ciprian Catana; Jacob M Hooker; Bruce R Rosen
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

5.  Biomathematical screening of amyloid radiotracers with clinical usefulness index.

Authors:  Ying-Hwey Nai; Miho Shidahara; Chie Seki; Hiroshi Watabe
Journal:  Alzheimers Dement (N Y)       Date:  2017-09-19

6.  Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation.

Authors:  J Paul Hamilton; Matthew D Sacchet; Trine Hjørnevik; Frederick T Chin; Bin Shen; Robin Kämpe; Jun Hyung Park; Brian D Knutson; Leanne M Williams; Nicholas Borg; Greg Zaharchuk; M Catalina Camacho; Sean Mackey; Markus Heilig; Wayne C Drevets; Gary H Glover; Sanjiv S Gambhir; Ian H Gotlib
Journal:  Transl Psychiatry       Date:  2018-11-30       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.